Vorexlan Unveiled: How Vorexlan Emerges as the Most Advanced Platform for Portfolio Automation and Real-Time Market Intelligence

New York City, NY, Dec. 02, 2025 (GLOBE NEWSWIRE) — What Is Vorexlan? Inside the 2026 Automated Trading Platform Vorexlan is a automated trading system engineered to streamline market participation through real-time analytics, automated trade execution, and AI-powered decision support. Designed as a multi-asset platform, Vorexlan integrates advanced computational models to help users analyze market […]

Bragar Eagel & Squire, P.C. Reminds Stockholders of Sprouts Farmers Market and Avantor to Contact the Firm Before Upcoming Deadlines

Bragar Eagel & Squire, P.C. Reminds Stockholders of Sprouts Farmers Market and Avantor to Contact the Firm Before Upcoming Deadlines GlobeNewswire December 02, 2025 NEW YORK, Dec. 02, 2025 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of

Vorexlan Unveiled: How Vorexlan Emerges as the Most Advanced Platform for Portfolio Automation and Real-Time Market Intelligence

Vorexlan Unveiled: How Vorexlan Emerges as the Most Advanced Platform for Portfolio Automation and Real-Time Market Intelligence Vorexlan is a automated trading platform offering real-time analytics, AI-driven portfolio automation, global asset access, and secure broker-integrated execution. GlobeNewswire December 02, 2025 New York City, NY, Dec. 02, 2025 (GLOBE NEWSWIRE) — What Is Vorexlan? Inside the

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:MIST), MONTREAL and CHARLOTTE, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) — Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity awards, in the form of a total of 30,000 options (the “Options”) to purchase the Company's common shares, pursuant to the Company's 2021 Inducement Plan (the “Plan”), previously

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire December 02, 2025 MONTREAL and CHARLOTTE, N.C., Dec. 02, 2025 (GLOBE NEWSWIRE) — Milestone Pharmaceuticals Inc. (Nasdaq: MIST) (the “Company” or “Milestone”), today announced that the Company granted equity awards, in the form of a total of 30,000 options (the “Options”) to purchase the

Levin Papantonio Donates $25,000 to “Communities Caring at Christmas” to Support Local Families in Need

PENSACOLA, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) — Levin Papantonio law firm proudly continued its long-standing tradition of holiday giving today with a $25,000 donation to Communities Caring at Christmas, a local program dedicated to helping families in Escambia County during the holiday season. The check presentation took place Tuesday, December 2, 2025, and was

Levin Papantonio Donates $25,000 to “Communities Caring at Christmas” to Support Local Families in Need

Levin Papantonio Donates $25,000 to “Communities Caring at Christmas” to Support Local Families in Need GlobeNewswire December 02, 2025 PENSACOLA, Fla., Dec. 02, 2025 (GLOBE NEWSWIRE) — Levin Papantonio law firm proudly continued its long-standing tradition of holiday giving today with a $25,000 donation to Communities Caring at Christmas, a local program dedicated to helping

Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability – Hagens Berman

(NASDAQ:TLX), SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Ltd. (NASDAQ: TLX), a commercial-stage biopharmaceutical company specializing in diagnostic and therapeutic radiopharmaceuticals, is now the target of a securities class action lawsuit following a series of regulatory setbacks and steep stock declines over the summer. Hagens Berman is actively investigating the allegations and

Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability – Hagens Berman

Telix Pharmaceuticals (TLX) Sued After Alleged Misstatements on Prostate Cancer Drug Progress and Supply Chain Reliability – Hagens Berman TLX Investors with Losses Encouraged to Contact Hagens Berman GlobeNewswire December 02, 2025 SAN FRANCISCO, Dec. 02, 2025 (GLOBE NEWSWIRE) — Telix Pharmaceuticals Ltd. (NASDAQ: TLX), a commercial-stage biopharmaceutical company specializing in diagnostic and therapeutic radiopharmaceuticals,

SalesHood Announces Enhanced Agentic AI-Powered Digital Sales Rooms to Increase Pipeline Velocity and Win Rates

San Francisco, California, Dec. 02, 2025 (GLOBE NEWSWIRE) — SalesHood, the leading Agentic AI sales enablement platform, today announced significant updates to its AI-driven Digital Sales Rooms, reinforcing its leadership in the market and delivering a measurable impact on customer revenue growth. With over $1B in pipeline managed and influenced through SalesHood Client Sites, organizations

Scroll to Top